Showing results (211-220 of 461) with videos related to

Sort By:
Pageof 47
Haematologica|July 24, 2025
Altered platelet lipidome in bleeding patients with unexplained platelet function defectsBianca De Jonckheere, Dino Mehic, Dominik Kopczynski, et al.
Atherosclerosis|March 4, 2020
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysisOliver Königsbrügge, Sabine Schmaldienst, Martin Auinger, et al.
Blood Advances|December 22, 2020
Human milk triggers coagulation via tissue factor-exposing extracellular vesiclesYong Hu, Lena Hell, Ruth Anna Kendlbacher, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Research and Practice in Thrombosis and Haemostasis - a new ISTH publishing platform for the global thrombosis and hemostasis communityIngrid Pabinger, Thomas Reiser, Jeffrey I Weitz
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Thrombosis Research|February 4, 2023
Platelet function and soluble P-selectin in patients with primary immune thrombocytopeniaDino Mehic, Jennifer Machacek, Theresa Schramm, et al.
Haematologica|January 19, 2007
Rituximab for the treatment of acquired antibodies to factor VIIIWolfgang R Sperr, Klaus Lechner, Ingrid Pabinger
Hamostaseologie|July 30, 2020
Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and FutureNick van Es, Cihan Ay, Luis Jara-Palomares
European Journal of Clinical Investigation|January 3, 2014
Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial diseaseThomas Gremmel, Renate Koppensteiner, Cihan Ay, et al.
Plos One|January 5, 2017
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)Oliver Königsbrügge, Florian Posch, Marlies Antlanger, et al.
Pageof 47